Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Up 100.8% in December

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 26,100 shares, an increase of 100.8% from the November 30th total of 13,000 shares. Based on an average daily trading volume, of 58,400 shares, the short-interest ratio is currently 0.4 days.

Cardio Diagnostics Price Performance

NASDAQ CDIOW traded up $0.01 on Friday, hitting $0.10. 23,626 shares of the company traded hands, compared to its average volume of 31,163. The business’s 50 day moving average price is $0.05 and its 200-day moving average price is $0.04. Cardio Diagnostics has a 52-week low of $0.02 and a 52-week high of $0.28.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.